GO:1990609 glutamate-cysteine ligase regulator activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990609 (glutamate-cysteine ligase regulator activity) is a molecular function describing proteins that bind to and modulate the activity of glutamate-cysteine ligase (GCL), the rate-limiting enzyme of glutathione synthesis.
• GCL is a heterodimer of the catalytic subunit GCLC and the modifier subunit GCLM; regulator proteins tune its catalytic output rather than replacing it.
• Regulation of GCL activity controls cellular glutathione (GSH) levels, which are central to redox homeostasis and protection against ferroptosis [1,6].
• Post-translational inputs such as lactylation, ISG15 conjugation, desuccinylation and ER-stress signaling converge on GCL to adjust glutathione synthesis [3,4,6,8].
• Dysregulated GCL regulation is implicated in cancer chemoresistance, ferroptosis evasion, hepatocellular carcinoma and age-related glutathione decline [3,5,7].
• CRISPR knockout, point-mutation, knock-in and overexpression models are the main tools for causally testing GCL regulator function in cells and animals [1,5].
Description
Glutathione is the most abundant non-enzymatic antioxidant in mammalian cells, and its synthesis begins with the ATP-dependent ligation of glutamate and cysteine to form gamma-glutamylcysteine, a reaction catalyzed by glutamate-cysteine ligase (GCL). Because this step is rate-limiting, the activity of GCL is a principal determinant of cellular glutathione content and of the cell's capacity to buffer oxidative stress. GO:1990609, glutamate-cysteine ligase regulator activity, captures the molecular function of proteins that bind to and modulate GCL activity, thereby providing a controlled node through which glutathione synthesis can be adjusted. For researchers, GO:1990609 is important because it distinguishes true regulators of GCL from the enzyme subunits themselves and from downstream glutathione-utilizing enzymes. Experimental work has shown that GCL activity can be modulated by non-canonical substrates and by protein interactions that change its catalytic behavior, with direct consequences for ferroptosis sensitivity. Additional studies demonstrate that GCL subunits and their regulators are targeted by post-translational modifications and stress-responsive signaling, linking this molecular function to cancer biology and metabolic disease [3,4,6,8]. This article summarizes the QuickGO definition of GO:1990609, the mechanistic steps through which GCL regulators act, the genes and proteins involved, and the CRISPR-based models and readouts used to study them. All statements are anchored to published literature so that the content can support grant writing, target validation and experimental design.
glutamate-cysteine ligase regulator activity At A Glance
| GO ID | GO:1990609 |
|---|---|
| GO term | glutamate-cysteine ligase regulator activity |
| Ontology | molecular_function |
| Synonym | None listed in QuickGO |
| Definition | Binds to and modulates the activity of glutamate-cysteine ligase |
| Major function | Tuning the rate-limiting step of glutathione synthesis |
| Target enzyme | Glutamate-cysteine ligase (GCLC/GCLM heterodimer) |
| Biological outcome | Altered glutathione levels, redox balance and ferroptosis sensitivity |
| Disease relevance | Cancer chemoresistance, ferroptosis evasion, hepatocellular carcinoma, age-related glutathione decline |
What Is GO:1990609?
GO:1990609, glutamate-cysteine ligase regulator activity, is a molecular function term defined as binding to and modulating the activity of glutamate-cysteine ligase. In practical terms, a protein annotated with this term physically associates with GCL and changes its catalytic output, either enhancing or restraining the conversion of glutamate and cysteine into gamma-glutamylcysteine. This function is distinct from the catalytic activity of GCLC itself and from the structural or modulatory role of GCLM; it describes the regulatory interaction layer that tunes glutathione synthesis.
Why Is glutamate-cysteine ligase regulator activity Important in Cell Biology?
GO:1990609 matters because glutathione synthesis is a central protective pathway, and its rate-limiting enzyme is controlled not only by substrate availability but also by regulatory interactions. Proteins that bind and modulate GCL can shift the threshold at which cells survive oxidative insults, and this has direct implications for ferroptosis, chemotherapy response and metabolic liver disease [1,3,5,6]. Understanding this regulatory layer helps researchers interpret why glutathione levels differ across cell states and how to target them therapeutically.
• Controls the rate-limiting step of glutathione synthesis, a major cellular antioxidant defense.
• Determines sensitivity to ferroptosis, an iron-dependent form of cell death relevant to cancer and neurodegeneration [1,6].
• Modulates chemoresistance in colorectal cancer through GCL-related moonlighting functions.
• Links ER-stress signaling (IRE1alpha) to glutathione synthesis capacity.
• Is affected by post-translational modifications such as lactylation, ISG15 conjugation and desuccinylation [3,4,6].
• Contributes to age-related decline in cellular glutathione and to the therapeutic potential of gamma-glutamylcysteine.
• Provides a mechanistic explanation for non-canonical GCL activity that protects cells from lipid peroxidation.
• Offers candidate targets for modulating redox balance in hepatocellular carcinoma and other tumors.
• Supports interpretation of glutathione-related drug resistance in precision oncology.
• Guides design of CRISPR models to test causality of GCL regulators in disease phenotypes [1,5].
Molecular Mechanism of glutamate-cysteine ligase regulator activity
Substrate recognition and GCL binding
In simple terms: A regulator protein first has to find and attach to the GCL enzyme.
Proteins with glutamate-cysteine ligase regulator activity bind to the GCL heterodimer, which consists of the catalytic subunit GCLC and the modifier subunit GCLM. This binding event positions the regulator to influence the enzyme's conformation or access to substrates. Non-canonical GCL activity has been described in which the enzyme uses alternative substrates to protect cells from ferroptosis, indicating that regulator binding can reshape substrate preference.
Modulation of catalytic output
In simple terms: Once bound, the regulator changes how fast or how well GCL makes its product.
After binding, regulators modulate the catalytic conversion of glutamate and cysteine into gamma-glutamylcysteine, the rate-limiting step of glutathione synthesis. This modulation can be positive or negative and can alter the cell's total glutathione pool. Studies of GCL subunit modifications show that changes in the enzyme's modification state, such as desuccinylation, can protect cancer cells from ferroptosis by sustaining GCL function.
Post-translational control of regulator and enzyme
In simple terms: Chemical tags added to GCL or its regulators can switch their activity up or down.
Post-translational modifications provide a layer of control over GCL regulation. NSUN2 lactylation enhances GCLC-dependent glutathione synthesis and drives ferroptosis resistance in cancer cells. ISG15 conjugation enhances gamma-glutamate cysteine ligase activity and suppresses apoptosis in high-fat-diet-promoted hepatocellular carcinoma. GCLC desuccinylation regulated by oxidative stress protects human cancer cells from ferroptosis. Together these findings show that the regulatory function of GO:1990609 is responsive to metabolic and stress signals.
Integration with stress and ER signaling
In simple terms: Stress pathways in the cell can dial GCL regulation up or down.
The unfolded protein response sensor IRE1alpha determines ferroptosis sensitivity through regulation of glutathione synthesis, linking ER stress to GCL-dependent redox control. This integration means that glutamate-cysteine ligase regulator activity is not isolated but sits within signaling networks that sense oxidative and proteotoxic stress. Such crosstalk helps explain why glutathione levels fluctuate across physiological and pathological states [2,7].
Downstream consequences for redox balance and cell fate
In simple terms: The end result of GCL regulation is either more or less glutathione, which decides whether a cell survives stress.
Because GCL activity sets the pace of glutathione synthesis, its regulators directly influence redox homeostasis and cell survival. Enhanced GCL regulation can protect cancer cells from ferroptosis and apoptosis, contributing to chemoresistance [3,4,5,6]. Conversely, age-related decline in cellular glutathione has been linked to reduced GCL function, and gamma-glutamylcysteine has been explored as a therapeutic means to bypass this decline.
Key Genes Involved in GO:1990609 glutamate-cysteine ligase regulator activity
The following genes and proteins are central to glutamate-cysteine ligase regulator activity, either as the enzyme subunits being regulated or as modifiers and signaling components that modulate GCL function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GCLC | Catalytic subunit of glutamate-cysteine ligase; performs the rate-limiting ligation step | Core target of regulator activity and of post-translational control [2,6] |
| GCLM | Modifier subunit of GCL; modulates catalytic efficiency and can have moonlighting functions | Nucleus-translocated GCLM promotes chemoresistance in colorectal cancer |
| NSUN2 | RNA methyltransferase whose lactylation enhances GCLC-dependent glutathione synthesis | Drives cancer cell resistance to ferroptosis |
| ISG15 | Ubiquitin-like modifier that enhances gamma-glutamate cysteine ligase activity | Suppresses apoptosis in high-fat-diet-promoted hepatocellular carcinoma |
| IRE1alpha (ERN1) | ER stress sensor that regulates glutathione synthesis | Determines ferroptosis sensitivity through GSH synthesis |
| SLC7A11 | Cystine transporter supplying cysteine for GCL reaction | Context for substrate availability in glutathione synthesis |
| GSS | Glutathione synthetase; converts gamma-glutamylcysteine to glutathione | Downstream enzyme defining the end product of GCL activity |
| GPX4 | Glutathione peroxidase that uses GSH to detoxify lipid peroxides | Effector of ferroptosis protection downstream of GCL |
| ACSL4 | Lipid metabolism enzyme contributing to ferroptosis sensitivity | Context for interpreting GCL regulator effects on ferroptosis |
| NFE2L2 (NRF2) | Transcription factor controlling antioxidant gene expression | Upstream regulator of glutathione pathway genes |
| ATF4 | Stress-responsive transcription factor linked to amino acid and redox homeostasis | Connects ER stress to glutathione synthesis |
| SLC3A2 | Partner of cystine transporter, supporting cysteine supply | Supports substrate provision for GCL |
| GGT1 | Gamma-glutamyl transferase involved in glutathione turnover | Context for glutathione metabolism |
| G6PD | Pentose phosphate pathway enzyme supplying NADPH for GSH recycling | Redox context for GCL regulation |
| SLC1A1 | Glutamate transporter influencing intracellular glutamate pools | Substrate context for GCL activity |
| CBS | Transsulfuration enzyme contributing to cysteine availability | Supports substrate supply for glutathione synthesis |
How Is glutamate-cysteine ligase regulator activity Regulated?
Glutamate-cysteine ligase regulator activity is regulated at multiple levels. Transcriptionally, antioxidant response elements drive expression of GCL subunits and related genes. Post-translationally, lactylation of NSUN2 enhances GCLC-dependent glutathione synthesis, ISG15 conjugation enhances gamma-glutamate cysteine ligase activity, and oxidative-stress-regulated desuccinylation of GCLC protects cancer cells from ferroptosis. Signaling through the ER stress sensor IRE1alpha further determines ferroptosis sensitivity by regulating glutathione synthesis. These layers allow cells to adjust GCL output rapidly in response to metabolic, oxidative and proteotoxic stress.
glutamate-cysteine ligase regulator activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GCLC | Ferroptosis resistance in cancer | GCLC knockout and point-mutation cell lines with ferroptosis inducers [1,6] |
| GCLM | Colorectal cancer chemoresistance | GCLM knockout and nuclear-localization mutants in colorectal cancer cells |
| NSUN2 | Ferroptosis resistance via GCLC-dependent GSH synthesis | NSUN2 knockout and lactylation-site mutants in cancer cells |
| ISG15 | Hepatocellular carcinoma in high-fat diet models | ISG15 knockout mice and hepatoma cell lines |
| ERN1 (IRE1alpha) | Ferroptosis sensitivity and ER stress | IRE1alpha knockout cells with glutathione and ferroptosis readouts |
Cancer chemoresistance and ferroptosis evasion
Enhanced regulation of GCL activity supports glutathione synthesis and helps cancer cells avoid ferroptosis and apoptosis. NSUN2 lactylation drives cancer cell resistance to ferroptosis through GCLC-dependent glutathione synthesis, and ISG15 enhances gamma-glutamate cysteine ligase activity to suppress apoptosis in high-fat-diet-promoted hepatocellular carcinoma. GCLC desuccinylation under oxidative stress similarly protects human cancer cells from ferroptosis. In colorectal cancer, nucleus-translocated GCLM promotes chemoresistance through a moonlighting function. These findings position GO:1990609 as a modifier of therapeutic response.
Ferroptosis and oxidative stress-related pathology
Non-canonical glutamate-cysteine ligase activity protects against ferroptosis, highlighting how GCL regulation can determine cell fate under lipid peroxidation stress. IRE1alpha determines ferroptosis sensitivity through regulation of glutathione synthesis, connecting ER stress to this death pathway. Because glutathione is a major antioxidant, dysregulation of GCL regulator activity may contribute to oxidative damage in multiple tissues.
Age-related glutathione decline and metabolic liver disease
Glutamate cysteine ligase and the age-related decline in cellular glutathione have been reviewed in the context of the therapeutic potential of gamma-glutamylcysteine. In metabolic liver disease, ISG15-mediated enhancement of GCL activity suppresses apoptosis in high-fat-diet-promoted hepatocellular carcinoma, indicating that GCL regulation intersects with diet-driven liver pathology.
From glutamate-cysteine ligase regulator activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate regulator required for GCL activity? | CRISPR knockout of the candidate gene followed by GCL activity and GSH assays |
| Does a specific residue control regulator function? | Point-mutation knock-in of the modified residue in the regulator or GCLC |
| Does a disease-associated variant alter GCL regulation? | Knock-in of the variant allele in isogenic cell lines |
| Where does the regulator interact with GCL? | Tagged knock-in with epitope or fluorescent tag for imaging and co-IP |
| Does overexpression of the regulator change ferroptosis sensitivity? | Doxycycline-inducible overexpression in cancer cell lines [1,3] |
| Does loss of the regulator alter tumor growth in vivo? | Xenograft or orthotopic models using knockout cells [4,5] |
How to Study the glutamate-cysteine ligase regulator activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| GCL activity assay | Rate of gamma-glutamylcysteine formation | Testing regulator impact on enzyme output |
| Total glutathione assay | Cellular GSH and GSSG levels | Readout of pathway flux [2,7] |
| Lipid peroxidation assay | Lipid ROS accumulation | Ferroptosis sensitivity testing [1,6] |
| Co-immunoprecipitation | Physical interaction between regulator and GCL | Confirming binding |
| Western blot | Protein levels and modification states | Detecting lactylation, ISG15, succinylation [3,4,6] |
| RNA sequencing | Transcriptional changes after perturbation | Mapping antioxidant response programs [2,5] |
| Proteomics | Global protein abundance and modifications | Identifying pathway crosstalk [3,4] |
| Cell viability assay | Survival under oxidative or ER stress | Linking GCL regulation to cell fate [1,8] |
Measuring GCL activity and glutathione levels
Biochemical assays for GCL activity and total glutathione are the primary readouts for glutamate-cysteine ligase regulator activity. These assays can be combined with genetic perturbation to determine whether a candidate regulator changes the rate of gamma-glutamylcysteine formation. Gamma-glutamylcysteine levels can also be measured as a proxy for GCL flux.
Ferroptosis and oxidative stress assays
Because GCL regulation influences ferroptosis, lipid peroxidation and cell viability assays using ferroptosis inducers are widely used [1,6]. Comparing wild-type and regulator-mutant cells under these conditions reveals whether the regulator protects or sensitizes cells. IRE1alpha status can be included to assess ER-stress crosstalk.
Post-translational modification analysis
Immunoprecipitation followed by mass spectrometry or western blotting can detect modifications such as lactylation, ISG15 conjugation and desuccinylation on GCL subunits and their regulators [3,4,6]. These methods help establish which modification states correlate with altered GCL activity.
Transcriptomic and proteomic profiling
RNA sequencing and proteomics can reveal how perturbation of a GCL regulator reshapes antioxidant gene programs and glutathione pathway components [2,5]. Such profiling places GO:1990609 within broader stress-response networks and can identify compensatory changes.
How CRISPR Can Be Used to Study GO:1990609 glutamate-cysteine ligase regulator activity
Knockout
CRISPR knockout of candidate regulators is used to test whether loss of the protein changes GCL activity, glutathione levels and ferroptosis sensitivity [1,5]. Knockout of GCLC or GCLM provides a baseline for comparing regulator-specific effects. These models are essential for establishing necessity.
Point Mutation
Point-mutation models allow precise testing of residues involved in regulator binding or post-translational modification. For example, mutation of desuccinylation sites on GCLC can reveal how modification state affects ferroptosis protection. Similar approaches can be applied to lactylation or ISG15 conjugation sites [3,4].
Knock-in
Knock-in of tagged alleles or disease-associated variants enables visualization of regulator localization and interaction with GCL. Tagged GCLM or GCLC can be used to study nuclear translocation and moonlighting functions relevant to chemoresistance. Variant knock-in helps determine whether specific alleles alter GCL regulation.
Overexpression
Overexpression of a candidate regulator can test sufficiency for increased glutathione synthesis and ferroptosis resistance [1,3]. Inducible systems allow dose- and time-controlled experiments. Overexpression combined with knockout of endogenous regulators helps separate direct from indirect effects.
How EDITGENE Supports glutamate-cysteine ligase regulator activity Research
Researchers studying glutamate-cysteine ligase regulator activity-related genes often need to determine whether a candidate gene is causally involved in glutathione synthesis, ferroptosis sensitivity or chemoresistance. EDITGENE provides CRISPR-based cell models and screening services that allow precise manipulation of GCL regulators and their modification sites.
Contact EDITGENE today to design your custom CRISPR model for glutamate-cysteine ligase regulator activity research.
Frequently Asked Questions About glutamate-cysteine ligase regulator activity
What is glutamate-cysteine ligase regulator activity?
It is a molecular function (GO:1990609) in which a protein binds to and modulates the activity of glutamate-cysteine ligase, the rate-limiting enzyme of glutathione synthesis.
What genes are involved in glutamate-cysteine ligase regulator activity?
Key genes include GCLC and GCLM, which form the enzyme, and modifiers such as NSUN2, ISG15 and IRE1alpha that influence its activity [2,3,4,8].
Why is GO:1990609 important for cancer research?
Because enhanced GCL regulation supports glutathione synthesis and helps cancer cells resist ferroptosis and chemotherapy [3,5,6].
How is glutamate-cysteine ligase activity measured?
Common methods include GCL activity assays and total glutathione measurements, often combined with genetic perturbation [2,7].
What is the relationship between GCL regulation and ferroptosis?
Non-canonical GCL activity and its regulators protect cells from ferroptosis by maintaining glutathione and limiting lipid peroxidation [1,6].
Which post-translational modifications regulate GCL?
Lactylation, ISG15 conjugation and desuccinylation have all been shown to modulate GCL function [3,4,6].
Can CRISPR be used to study GCL regulators?
Yes, knockout, point-mutation, knock-in and overexpression models are widely used to test causality [1,5].
What diseases are linked to GCL dysregulation?
Cancer chemoresistance, hepatocellular carcinoma, ferroptosis-related pathology and age-related glutathione decline [4,5,7].
How does ER stress affect GCL regulation?
The IRE1alpha branch of the unfolded protein response regulates glutathione synthesis and ferroptosis sensitivity.
What cell models are best for studying GO:1990609?
Isogenic knockout and knock-in cell lines combined with glutathione and ferroptosis assays provide robust causal evidence [1,2,5].
Conclusion
GO:1990609, glutamate-cysteine ligase regulator activity, defines the regulatory layer that tunes the rate-limiting step of glutathione synthesis. Through binding and modulation of GCL, regulator proteins influence redox balance, ferroptosis sensitivity and chemotherapy response, with documented roles in cancer and metabolic liver disease [1,3,5,6,8]. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with glutathione and ferroptosis assays, provide the experimental framework to dissect these regulators. EDITGENE supports this workflow with custom cell model generation, library screening and bioinformatics services.
References
- 1. Kang YP et al.. 2021. Non-canonical Glutamate-Cysteine Ligase Activity Protects against Ferroptosis.. Cell Metab 33(1):174-189.e7 PMID: 33357455
- 2. Lu SC. 2013. Glutathione synthesis.. Biochim Biophys Acta 1830(5):3143-53 PMID: 22995213
- 3. Niu K et al.. 2025. NSUN2 lactylation drives cancer cell resistance to ferroptosis through enhancing GCLC-dependent glutathione synthesis.. Redox Biol 79:103479 PMID: 39742570
- 4. Liu X et al.. 2025. ISG15 Enhances the Activity of γ-Glutamate Cysteine Ligase to Suppress Apoptosis in High Fat Diet-Promoted Hepatocellular Carcinoma.. Adv Sci (Weinh) 12(19):e2416401 PMID: 40126377
- 5. Lin JF et al.. 2025. Nucleus-translocated GCLM promotes chemoresistance in colorectal cancer through a moonlighting function.. Nat Commun 16(1):263 PMID: 39747101
- 6. Chen Z et al.. 2025. GCLC desuccinylation regulated by oxidative stress protects human cancer cells from ferroptosis.. Cell Death Differ 32(9):1679-1690 PMID: 40188196
- 7. Ferguson G et al.. 2016. Glutamate cysteine ligase and the age-related decline in cellular glutathione: The therapeutic potential of γ-glutamylcysteine.. Arch Biochem Biophys 593:12-23 PMID: 26845022
- 8. Jiang D et al.. 2024. IRE1α determines ferroptosis sensitivity through regulation of glutathione synthesis.. Nat Commun 15(1):4114 PMID: 38750057
